Soleno Therapeutics (SLNO) had the highest return between December 1, 2022 and December 31, 2024 by a mid-cap US stock, returning 3,525%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 12/1/2022 - 12/31/2024 | 3,525% |
SoundHound AI (SOUN) | 12/1/2022 - 12/31/2024 | 1,437.98% |
Rigetti Computing (RGTI) | 12/1/2022 - 12/31/2024 | 1,030.37% |
Viking Therapeutics (VKTX) | 12/1/2022 - 12/31/2024 | 891.13% |
Powell Industries (POWL) | 12/1/2022 - 12/31/2024 | 756.19% |
Banco Macro SA B ADR (BMA) | 12/1/2022 - 12/31/2024 | 707.28% |
BBVA Banco Frances SA ADR (BBAR) | 12/1/2022 - 12/31/2024 | 647.33% |
Terawulf (WULF) | 12/1/2022 - 12/31/2024 | 573.81% |
Iris Energy (IREN) | 12/1/2022 - 12/31/2024 | 563.51% |
Abercrombie & Fitch (ANF) | 12/1/2022 - 12/31/2024 | 525.66% |
IES (IESC) | 12/1/2022 - 12/31/2024 | 489.33% |
Empresa Distribuidora y Comercializadora Norte SA ADR (EDN) | 12/1/2022 - 12/31/2024 | 485.4% |
GeneDx (WGS) | 12/1/2022 - 12/31/2024 | 454.55% |
Modine Manufacturing (MOD) | 12/1/2022 - 12/31/2024 | 449.43% |
MoonLake Immunotherapeutics (MLTX) | 12/1/2022 - 12/31/2024 | 448.08% |
Scholar Rock (SRRK) | 12/1/2022 - 12/31/2024 | 445.71% |
SkyWest (SKYW) | 12/1/2022 - 12/31/2024 | 438.62% |
ADMA Biologics (ADMA) | 12/1/2022 - 12/31/2024 | 422.87% |
Sterling Construction (STRL) | 12/1/2022 - 12/31/2024 | 408.14% |
Protagonist Therapeutics (PTGX) | 12/1/2022 - 12/31/2024 | 387.37% |
Cellebrite DI (CLBT) | 12/1/2022 - 12/31/2024 | 386.31% |
United States Lime & Minerals (USLM) | 12/1/2022 - 12/31/2024 | 384.28% |
Nextnav Acquisition (NN) | 12/1/2022 - 12/31/2024 | 372.95% |
Oscar Health (OSCR) | 12/1/2022 - 12/31/2024 | 360.27% |
Madrigal Pharmaceuticals (MDGL) | 12/1/2022 - 12/31/2024 | 336.94% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
